Preview

Epidemiology and Vaccinal Prevention

Advanced search

xperimental Evaluation of the Possibility of using the LAL test to Determine Bacterial Endotoxins in Vaccines for Rabies Prophylaxis

https://doi.org/10.31631/2073-3046-2021-20-5-115-122

Abstract

Relevance. The presence of pyrogenic impurities in finished dosage forms of concentrated cultural anti-rabies vaccines produced in the Russian Federation is determined using pyrogenicity tests on rabbits (in vivo). In accordance with the decision of the Board of the Eurasian Economic Commission dated September 7, 2018 N 151 «On the approval of guidelines for drawing up a regulatory document on the quality of a medicinal product», one of the requirements for parenteral drugs is the determination of bacterial endotoxins. This document indicates that the regulatory documentation should include a test and an admissibility criterion for bacterial endotoxins (BE) using the horseshoe crab amoebocyte lysate technique.

Aims. Experimental evaluation of the possibility of using the LAL-test to determine bacterial endotoxins in national vaccines for the prevention of rabies.

Materials and methods. The research of the drug «Cultural antirabies vaccine concentrated inactivated purified» of national production was carried out in accordance with the National Pharmacopoeia of the Russian Federation, General Pharmacopoeia Monograph OFS.1.2.4.0006.15 in three modifications: gel-clot test: methods A, B; turbidimetric kinetic test: method C; chromogenic kinetic test: method D.

Results. Was investigated 6 series of the national vaccines for the prevention of rabies from two national manufacturers (using three pharmacopoeial methods). LAL reagent produced by two companies (Charles River Endosafe® and Lonza). In order to confirm the reproducibility of the method, the gel-clot test was carried out at different time intervals by one or two operators. During the research was determined the possibility of using photometric methods (method C and D).

Conclusions. The research proved the possibility of determining bacterial endotoxins by methods: gel-clot test (method A), turbidimetric kinetic test (method C) and chromogenic kinetic test (method D). Method B is recommended for quantitative analysis of vaccine without instrumental methods. During the research all national vaccines for the prevention of rabies was free from bacterial endotoxins (no more 25 EU/ml).

About the Authors

A. V. Muhacheva
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Anastasija V. Muhacheva – Leading expert of the viral vaccine laboratory

Moscow

+7 (499)190-18-18



O. A. Barkhaleva
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Oksana А. Barhaleva – Main expert of the viral vaccine laboratory

Moscow

+7 (499)190-18-18



O. V. Shapovalova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Ol’ga V. Shapovalova – Leading expert of the Pharmacology Laboratory

Moscow

+7 (495) 625-43-48



N. P. Neugodova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Natalija P. Neugodova – Chief of the Pharmacology Laboratory

Moscow

+7 (495) 625-43-48



A. Yu. Butirskiy
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Aleksej Ju. Butyrskij  – Main expert of the viral vaccine laboratory

Moscow

+7 (499)190-18-18



A. A. Movsesyants
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Artashes A. Movsesjanc  – Chief of the Testing Center for Evaluation of MIBP Quality

Moscow

+7 (499) 190-18-18



R. A. Volkova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Rauza A. Volkova  – Chief of the laboratory for molecular biological and genetic testing methods

Moscow

+7 (499) 190-18-18



K. A. Sarkisyan
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Karinje A. Sarkisjan – Chief of the viral vaccine laboratory

Moscow

+7 (499) 190-18-18



References

1. Board of the Eurasian Economic Commission dated September 7, 2018 N 151 « On the approval of guidelines for drawing up a regulatory document on the quality of a medicinal product » «. Available at: https://www.alta.ru/tamdoc/18kr0151/. Accessed: 01.02.2021.

2. European Pharmacopoeia 9th Edition.

3. Pharmacopoeia of the Russian Federation. Available at: http://femb.ru/femb/pharmacopea.php. Accessed: 01.02.2021.

4. Kevin L. Williams. Endotoxins: Pyrogens, LAL Testing and Depyrogenation (Drugs and the Pharmaceutical Sciences Book 167) 3rd Edition. Eli Lilly & Company Indianapolis, Indiana, U.S.A. Chapter 7. Nonendotoxin Microbial Pyrogens: Lesser Endotoxins and Superantigens p.133.

5. Shapovalova O.V., Neugodova N.P., Ryabtseva M.S., et al. Alternative biological methods for assessing the quality of medicines. Farmaciya; 2017; 2: 7–10 (In Russ). DOI: https://doi.org/None. Available at: https://pharmaciyajournal.ru/ru/25419218-2017-02-02. Accessed: 01.02.2021.

6. Shapovalova O.V. Development of methodological approaches for determining the content of bacterial endotoxins in pharmaceutical substances [dissertation]. Moscow; 2018 (In Russ). Available at: https://www.dissercat.com/content/razrabotka-metodicheskikh-podkhodov-dlya-opredeleniya-soderzhaniya-bakterialnykh-endotoksino/read. Accessed: 01.02.2021.

7. Shapovalova O.V., Neugodova N.P., Sapozhnikova G.A. Choosing Bacterial Endotoxin Detection Method. Antibiotiki i khimioterapiya. 2018; 63 (5-6): 43–45. (In Russ). Scopus EID: 2-s2.0-85055337352. Available at: https://www.scopus.com/record/display.uri?eid=2-s2.0-85055337352&origin=inward&txGid=7e204826f26adec5a846bfc4b655a399 Accessed: 28.09.2021


Review

For citations:


Muhacheva A.V., Barkhaleva O.A., Shapovalova O.V., Neugodova N.P., Butirskiy A.Yu., Movsesyants A.A., Volkova R.A., Sarkisyan K.A. xperimental Evaluation of the Possibility of using the LAL test to Determine Bacterial Endotoxins in Vaccines for Rabies Prophylaxis. Epidemiology and Vaccinal Prevention. 2021;20(5):115-122. (In Russ.) https://doi.org/10.31631/2073-3046-2021-20-5-115-122

Views: 682


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)